alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › clinical-cohort

clinical-cohort

3 studies tagged clinical-cohort, dated 2015-02-01 to 2025-11-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Neuroimaging correlates and biomarker performance of a fully automated plasma p-tau217/Aβ42 ratio assay in a clinical cohort with Alzheimer's disease 2025-11-01
  2. The CORCOBIA study: Cut-off points of Alzheimer's disease CSF biomarkers in a clinical cohort 2022-08-09
  3. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study 2015-02-01

Studies

3 studies carry this tag.

Date range

2015 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Clinical chemistry and laboratory medicine 1
  • Neurologia 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Neuroimaging correlates and biomarker performance of a fully automated plasma p-tau217/Aβ42 ratio assay in a clinical cohort with Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-11-01 Biomarkers

    The p-tau217/Aβ42 ratio was the most reliable plasma biomarker, closely tracking tau PET.

  2. The CORCOBIA study: Cut-off points of Alzheimer's disease CSF biomarkers in a clinical cohort

    ✓ Peer-reviewed alzhub usefulness score 54 out of 100. Neurologia 2022-08-09 Biomarkers

    The determination of cut-off points of core AD CSF biomarkers for the participating centers allows a better diagnostic accuracy.

  3. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Clinical chemistry and laboratory medicine 2015-02-01 Biomarkers

    Our results confirm the key role of CSF biomarkers in predicting patient conversion from MCI to dementia.

All topic tags with their study counts